Close
Nordic 9Nordic 9

RA Capital Management (investor - Private Equity)

United States racap.com
See something wrong or missing? Let us know
Offices:Boston

RA Capital Management is a Multi-Stage Investment Manager, dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics.

Average round investment:96.13M USD
Average number per year:4.8
Distribution: 2026 (1)2025 (7)2024 (9)2023 (3)2022 (3) See the entire list
Portfolio companies: Denmark AdcendoDenmark EvodiabioDenmark Sidera Bio See the entire list
Mostly invests in: Denmark Denmark (11) Health services (27)
See the entire list

Showing 3 of 29 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

RA Capital Management mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to RA Capital Management

Name Criteria
Luxembourg GEM Digital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, France
  • Average number of deals per year: 5.5
  • Active last 12 months: Yes
United Kingdom GP Bullhound
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Food Industry, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, France, Germany
  • Average number of deals per year: 5.1
  • Active last 12 months: Yes
United States Bain Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, France, Germany
  • Average number of deals per year: 4.5
  • Active last 12 months: Yes
United States F-Prime Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Food Industry, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Italy, France
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
United States New Enterprise Associates
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, France, Germany
  • Average number of deals per year: 3.9
  • Active last 12 months: Yes
France AVP
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Food Industry, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, France, Germany
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
United Kingdom Felix Capital
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Food Industry, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France, Germany
  • Average number of deals per year: 7.6
  • Active last 12 months: Yes
United Kingdom Wellington Partners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Robotics, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: Denmark, United Kingdom, Switzerland, Italy, France, Germany
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
France Andera Partners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Robotics, Software Services, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Italy, France, Germany
  • Average number of deals per year: 5.5
  • Active last 12 months: Yes
Poland Mati Staniszewski
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 5.5
  • Active last 12 months: Yes
Top